Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer
Clinical trial NCT01545648 · TERMINATED
Trial details
- NCT number
- NCT01545648
- Sponsor
- Hope Rugo, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-06-09
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.